Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ChAdOx1 nCoV-19 Vaccine”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Testing effectiveness (Phase 2)UnknownNCT04444674
What this trial is testing

COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection

Who this might be right for
Coronavirus
University of Oxford 2,130
Large-scale testing (Phase 3)UnknownNCT04536051
What this trial is testing

A Candidate COVID-19 Vaccine (COV003)

Who this might be right for
Coronavirus
University of Oxford 10,300
Not applicableUnknownNCT05289206
What this trial is testing

Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity

Who this might be right for
Comorbidities and Coexisting ConditionsHealthy
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 4,446
Not applicableUnknownNCT05060861
What this trial is testing

Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

Who this might be right for
ChAdOx1 nCoV-19 Vaccine
Assiut University 2,000
Testing effectiveness (Phase 2)Study completedNCT04324606
What this trial is testing

A Candidate COVID-19 Vaccine (COV001)

Who this might be right for
Coronavirus
University of Oxford 1,077
Early research (Phase 1)Study completedNCT04816019
What this trial is testing

Intranasal ChAdOx1 nCOV-19

Who this might be right for
Coronavirus
University of Oxford 42
Not applicableStudy completedNCT05697705
What this trial is testing

Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study

Who this might be right for
COVID-19
AstraZeneca 188,814,085
Not applicableStudy completedNCT04961385
What this trial is testing

Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial

Who this might be right for
Covid19VaccineImmunogenicity
Bangkok Metropolitan Administration Medical College and Vajira Hospital 60
Post-approval studies (Phase 4)UnknownNCT05097053
What this trial is testing

A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19

Who this might be right for
COVID-19 Vaccine
Taoyuan General Hospital 200
Not applicableStudy completedNCT05074368
What this trial is testing

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

Who this might be right for
Healthy Adult Volunteers
National Taiwan University Hospital 499
Testing effectiveness (Phase 2)UnknownNCT04983537
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population

Who this might be right for
COVID-19 Vaccines
Ministerio de Salud de Ciudad Autónoma de Buenos Aires 120
Testing effectiveness (Phase 2)Study completedNCT04962906
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes

Who this might be right for
COVID-19 Vaccines
Ministerio de Salud de Ciudad Autónoma de Buenos Aires 192
Large-scale testing (Phase 3)UnknownNCT05059106
What this trial is testing

EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

Who this might be right for
SARS-CoV-2
Federal University of Espirito Santo 29,637
Not applicableUnknownNCT05315856
What this trial is testing

Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

Who this might be right for
COVID-19 VaccinationInflammationVaccine Immune Response+1 more
Korea University Guro Hospital 120
Large-scale testing (Phase 3)Study completedNCT04400838
What this trial is testing

Investigating a Vaccine Against COVID-19

Who this might be right for
Coronavirus
University of Oxford 10,811